Precision AQ

We’re proud to share that Vinitha Nair, Associate Director, Human Resources, was honored with the HR Leader of the Year award at the 2026 NexGen HR Tech Summit and Awards Conference. This recognition celebrates her outstanding leadership in advancing people and operational excellence. Vinitha’s thoughtful, people-first approach, combined with her commitment to delivering impactful, scalable solutions, has not only transformed how our teams in India operate but has also strengthened the culture that drives our success worldwide. Please join us in congratulating Vinitha on this well-deserved achievement! 👏 #NEXGENHRTech

Day 2 is in the books at ISPOR 2026. Our team enjoyed a full agenda of sessions and great conversations with attendees. - A refreshing mix of sessions beyond AI and JCA, with a strong focus on health equity methods and advancing outcomes in rare disease - Clients are actively exploring more accessible, affordable real-world data, moving beyond conventional sources to better align with their therapeutic areas - At the same time, many biopharma teams are navigating tension between senior internal stakeholders’ push to adopt AI for efficiency and researchers’ concerns around tool integrity, acceptability, and scientific validity The balance between innovation and rigor is clearly front and center. Looking forward to what the final day brings. #ISPOR2026 #HEOR #RWE #MarketAccess #HealthcareInnovation

The Precision AQ AccessGenius team is excited to be onsite at the Veeva Commercial Summit! There’s a lot of momentum across sessions, with conversations centered on data, AI-driven insights, and more connected, patient-focused commercialization strategies, making it exciting to see where the industry is heading. If you’re attending, be sure to stop by the booth and chat with our team! #VeevaSummit #AccessGenius

We are proud to share that the Precision AQ Advertising team has been recognized with 22 wins at the TITAN Health Awards, including six Platinum honors across advertising, marketing, and outstanding healthcare achievement categories. These awards reflect the collaborative work behind every engagement where data, creativity, and strategy come together to help our clients move markets and improve patient access. We also want to recognize our client and partner, Julie Garlikov of CareDx, Inc., who was honored as a Platinum winner in the Outstanding Healthcare Leader category. Julie’s leadership continues to advance innovation and access in meaningful ways, and we are proud to partner with her. To our teams and partners: thank you for pushing the work forward and setting a higher standard for what healthcare communication can achieve.

Before Day 2 at ISPOR 2026 gets underway, hear what stood out to our team from day one! We are excited to connect with everyone onsite today. Stop by booth #610 to meet our HEOR and Market Access experts. #ISPOR2026 #HEOR #MarketAccess

Our HEOR & Access Consulting is proud to be in Philadelphia for #ISPOR2026 joining over 4,500 global experts in health economics, outcomes research and market access. Day 1 brought rich discussions and insights: - Plenary session on US pharma policy covered pricing strategies, investment in resource-intensive emerging therapies, IRA vs. MFN dynamics, and the evolving role of PBMs. - Seminar on AI-LLM reinforced the need for “human-in-the-loop" oversight, especially in study design, data interpretation, and quality assurance, while showcasing impressive real-world applications embedded in HEOR workflows. - Energetic clients debating programs of work vs. single projects, a positive sign of growing demand. Additionally, our team showcased our expertise with posters and workshops throughout the day. If you'd like to connect onsite, make sure to stop by booth #610. #HEOR #PharmaPolicy #MarketAccess #MFN

We are live at ISPOR 2026! Tune in as Ross Maclean and Sarah Ronnebaum walk through our poster, “Trends and Postmarketing Outcomes of Accelerated Approvals (AAs) in FDA New Drug Applications and Biologic License Applications (NDAs/BLAs) from 1992-2025” From evolving regulatory pathways to what happens after accelerated approval, they share key insights and why this matters for today’s evidence landscape. It’s been an energizing start to the conference, and we’re excited to keep sharing what we’re seeing and hearing onsite over the next few days. Stay tuned for more highlights. #ISPOR2026 #HEOR #AcceleratedApproval #RealWorldEvidence

Precision AQ’s Learning & Development and Market Access teams are looking forward to attending LTEN, where industry leaders come together to advance commercial excellence across life sciences. We’re excited to engage in conversations around enabling high-performing teams, strengthening access strategies, and turning insight into impact as organizations navigate an increasingly complex market. If you’ll be at LTEN, we’d love to connect. Schedule a meeting with our team to explore how we can support your learning, development, and market access goals: https://hubs.ly/Q04gvRZZ0 #LTEN2026

We don’t just understand oncology access, we’ve delivered it more than 265 times. Our team brings deep, hands‑on experience and proven results to every challenge: - 265+ oncology products supported across all major tumor types - 145+ launches guided, including 16 multi‑indication, sequenced therapies - 450+ peer‑reviewed oncology publications - 7 board‑certified or oncology‑specialized PharmDs on staff - 20+ leaders with firsthand oncology access decision‑making experience - 100+ leading U.S. cancer centers in our network Headed to #ASCO26? Visit us at Booth #10119 or schedule a meeting to discuss your oncology access: https://hubs.ly/Q04dC_-60 #PrecisionAQ #OncologyLeadership #MarketAccess #CancerCare